Plasma-Lyte is a crystalloid solution for intravenous infusion, with varying electrolyte formulation depending on market. Generally the solution has a composition that mimics human physiological plasma electrolyte concentrations, osmolality and pH.1: Rizoli S. PlasmaLyte. J Trauma. 2011 May;70(5 Suppl):S17-8. doi: 10.1097/TA.0b013e31821a4d89. .
It is manufactured and marketed by Baxter International Inc.2: Baxter. Plasma-Lyte 148 product information. 2013. available at URL: http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/plasmalyte148_pi.pdf and available as a generic medication.
Plasma-lyte 148 (pH7.4)
Plasma-Lyte 148 is a market-specific solution available in the United Kingdom and Australia, among others and has the following composition: Sodium 140 mmol/L Potassium 5 mmol/L Magnesium 1.5 mmol/L Chloride 98 mmol/L Acetate 27 mmol/L Gluconate 23 mmol/L A Plasma-Lyte 148 with 5% glucose is also manufactured by Baxter.
References